Cintia Checa-Rodríguez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Cintia Checa-Rodríguez has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
- Pablo Huertas
Departamento de Genética, Facultad de Biología, Universidad de Sevilla
8 shared publications - Amadeo Jesus Wals Zurita
Department of Radiation Oncology, Hospital Universitario Virgen Macarena, Seville, Spain
2 shared publications Amador Romero-Franco
Facultad de Biología, Universidad de Sevilla, Sevilla, Spain
2 shared publications- Andres Joaquin Lopez-Contreras
Centro Andaluz de Biología Molecular y Medicina Regenerativa-CABIMER, Universidad de Sevilla-CSIC-Universidad Pablo de Olavide, Sevilla, Spain
2 shared publications - Beatriz Suárez Quintero
Instituto de Biomedicina de Sevilla, Universidad de Sevilla
2 shared publications - Daniel Gómez-Cabello
Instituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Seville, Spain
2 shared publications
Latest Publications
- Open Access
- 25 February 2026
- Published by Universidad de Sevilla - Servicio de Recursos Audiovisuales y Nuevas Tecnologias
Laboratorio virtual de genética: el proceso de edición génica con CRISPR-Cas9
La realización de este recurso tiene como objetivo facilitar el aprendizaje y la comprensión del proceso de edición génica mediante la tecnología CRISPR/Cas9, permitiendo al alumnado experimentarlo de forma inmersiva en un laboratorio virtual de genética. El uso de este recurso proporciona a los estudiantes la posibilidad de acceder a procedimientos experimentales avanzados que, en un entorno docente real, resultan difíciles de implementar debido a su complejidad técnica, los elevados costes asociados (equipamiento específico, reactivos, cultivos celulares) y las estrictas condiciones de bioseguridad requeridas. El recurso se apoya en la aplicación de metodologías de aprendizaje activo y gamificación, fomentando la participación del alumnado mediante una experiencia práctica, interactiva y guiada, lo que contribuye a aumentar la motivación y a mejorar la adquisición de conocimientos. Asimismo, esta herramienta permite al profesorado introducir al alumnado en una de las tecnologías más relevantes y actuales de la biología molecular y la genética, ampliamente utilizada en investigación biomédica, biotecnología y medicina. A lo largo de la simulación de realidad virtual, el alumnado dispone de materiales explicativos en formato texto y vídeo, elaborados por el profesorado implicado, en los que se revisan los fundamentos teóricos del sistema CRISPR/Cas9 y las distintas etapas del proceso de edición génica. El recurso recrea un laboratorio de genética y de cultivo celular completamente equipado, en el que el alumnado puede llevar a cabo de forma virtual todas las fases del procedimiento, desde el diseño del ARN guía hasta la introducción del sistema CRISPR/Cas9 en células en cultivo y el análisis de los resultados de la edición. A lo largo de la experiencia, el estudiante debe tomar decisiones, resolver actividades y responder a cuestiones que condicionan su progreso, emulando así el desarrollo real de un protocolo experimental en un laboratorio de genética. El recurso está disponible tanto en español como en inglés, lo que amplía su accesibilidad y lo convierte en una herramienta de utilidad tanto en contextos docentes nacionales como internacionales.
- 25 February 2026
- Published by Universidad de Sevilla - Servicio de Recursos Audiovisuales y Nuevas Tecnologias
Open AccessLaboratorio virtual de genética: el proceso de edición génica con CRISPR-Cas9
La realización de este recurso tiene como objetivo facilitar el aprendizaje y la comprensión del proceso de edición génica mediante la tecnología CRISPR/Cas9, permitiendo al alumnado experimentarlo de forma inmersiva en un laboratorio virtual de genética. El uso de este recurso proporciona a los estudiantes la posibilidad de acceder a procedimientos experimentales avanzados que, en un entorno docente real, resultan difíciles de implementar debido a su complejidad técnica, los elevados costes asociados (equipamiento específico, reactivos, cultivos celulares) y las estrictas condiciones de bioseguridad requeridas. El recurso se apoya en la aplicación de metodologías de aprendizaje activo y gamificación, fomentando la participación del alumnado mediante una experiencia práctica, interactiva y guiada, lo que contribuye a aumentar la motivación y a mejorar la adquisición de conocimientos. Asimismo, esta herramienta permite al profesorado introducir al alumnado en una de las tecnologías más relevantes y actuales de la biología molecular y la genética, ampliamente utilizada en investigación biomédica, biotecnología y medicina. A lo largo de la simulación de realidad virtual, el alumnado dispone de materiales explicativos en formato texto y vídeo, elaborados por el profesorado implicado, en los que se revisan los fundamentos teóricos del sistema CRISPR/Cas9 y las distintas etapas del proceso de edición génica. El recurso recrea un laboratorio de genética y de cultivo celular completamente equipado, en el que el alumnado puede llevar a cabo de forma virtual todas las fases del procedimiento, desde el diseño del ARN guía hasta la introducción del sistema CRISPR/Cas9 en células en cultivo y el análisis de los resultados de la edición. A lo largo de la experiencia, el estudiante debe tomar decisiones, resolver actividades y responder a cuestiones que condicionan su progreso, emulando así el desarrollo real de un protocolo experimental en un laboratorio de genética. El recurso está disponible tanto en español como en inglés, lo que amplía su accesibilidad y lo convierte en una herramienta de utilidad tanto en contextos docentes nacionales como internacionales.
- Open Access
- 1 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 10802
Circadian regulation of homologous recombination by cryptochrome1-mediated dampening of DNA end resection
Genomic stability maintenance requires the repair of DNA breaks in the most accurate fashion. So, an exquisite regulatory network controls the choice between different repair mechanisms to maximize genome integrity. This relies mostly at the level of DNA end resection, the initial steps of the homologous recombination. On the other hand, numerous cellular activities follow a 24 h oscillation known as the circadian cycle. Thus, we explored the regulation of the choice between different DNA break repair pathways along the circadian cycle. Here we show that in human cells DNA resection shows a circadian oscillation, with a peak at early morning followed by a partial and progressive reduction until late afternoon. Such regulation depends on the circadian clock core component CRY1, which modulates the anti-resection activity of CCAR2 to limit CtIP at nightfall. Additionally, such regulation requires DNA-PK-mediated phosphorylation of CRY1. Finally, this circadian regulation impacts cancer progression and response to radiation therapy of specific tumours.
- 1 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 10802
Open AccessCircadian regulation of homologous recombination by cryptochrome1-mediated dampening of DNA end resection
Genomic stability maintenance requires the repair of DNA breaks in the most accurate fashion. So, an exquisite regulatory network controls the choice between different repair mechanisms to maximize genome integrity. This relies mostly at the level of DNA end resection, the initial steps of the homologous recombination. On the other hand, numerous cellular activities follow a 24 h oscillation known as the circadian cycle. Thus, we explored the regulation of the choice between different DNA break repair pathways along the circadian cycle. Here we show that in human cells DNA resection shows a circadian oscillation, with a peak at early morning followed by a partial and progressive reduction until late afternoon. Such regulation depends on the circadian clock core component CRY1, which modulates the anti-resection activity of CCAR2 to limit CtIP at nightfall. Additionally, such regulation requires DNA-PK-mediated phosphorylation of CRY1. Finally, this circadian regulation impacts cancer progression and response to radiation therapy of specific tumours.
- Open Access
RNA Polymerase II-mediated transcription is required for repair of ribosomal DNA breaks in nucleolar caps, guarding against genomic instability
Ribosomal DNA (rDNA) double-strand breaks (DSBs) threaten genome integrity due to the repetitive and transcriptionally active nature of rDNA. The nucleolus, while central to ribosome biogenesis, also functions as stress sensor. Here, we identify a transcription-dependent mechanism in which RNA polymerase II (RNAPII) is essential for homologous recombination (HR) repair of rDNA DSBs. Using CRISPR-induced breaks, high-resolution imaging, and transcriptional inhibition, we show that RNAPII activity drives the formation of nucleolar repair caps. Mechanistically, CtIP promotes RNAPII recruitment and H3K36 trimethylation at rDNA lesions, facilitating HR. Disruption of this RNAPII–CtIP–H3K36me3 axis impairs cap formation and repair, leading to persistent damage. RNAPII inhibition exacerbates genome instability and synergizes with rDNA breaks to induce cancer cell death, without acutely impairing ribosome function. These findings uncover a co-transcriptional mechanism of rDNA repair and highlight RNAPII-mediated chromatin remodeling and spatial reorganization as key to nucleolar genome maintenance and potential targets for cancer therapy. Teaser: Nascent RNA synthesis by RNAPII safeguards ribosomal DNA integrity to avoid genomic instability in human cells. Graphical
Open AccessRNA Polymerase II-mediated transcription is required for repair of ribosomal DNA breaks in nucleolar caps, guarding against genomic instability
Ribosomal DNA (rDNA) double-strand breaks (DSBs) threaten genome integrity due to the repetitive and transcriptionally active nature of rDNA. The nucleolus, while central to ribosome biogenesis, also functions as stress sensor. Here, we identify a transcription-dependent mechanism in which RNA polymerase II (RNAPII) is essential for homologous recombination (HR) repair of rDNA DSBs. Using CRISPR-induced breaks, high-resolution imaging, and transcriptional inhibition, we show that RNAPII activity drives the formation of nucleolar repair caps. Mechanistically, CtIP promotes RNAPII recruitment and H3K36 trimethylation at rDNA lesions, facilitating HR. Disruption of this RNAPII–CtIP–H3K36me3 axis impairs cap formation and repair, leading to persistent damage. RNAPII inhibition exacerbates genome instability and synergizes with rDNA breaks to induce cancer cell death, without acutely impairing ribosome function. These findings uncover a co-transcriptional mechanism of rDNA repair and highlight RNAPII-mediated chromatin remodeling and spatial reorganization as key to nucleolar genome maintenance and potential targets for cancer therapy. Teaser: Nascent RNA synthesis by RNAPII safeguards ribosomal DNA integrity to avoid genomic instability in human cells. Graphical
- Open Access
Circadian regulation of Homologous Recombination by Cryptochrome1-mediated dampening of DNA end resection
The maintenance of genomic stability is essential for cellular and organismal survival and fitness. Thus, when DNA gets damaged, is essential to repair it in the most accurate fashion. Among different DNA lesions, DNA double strand breaks are specially challenging. An exquisite regulatory network reacts to local and global cues to control the choice between different DNA double strand break repair mechanisms to maximize genomic integrity. Such regulation relies mostly at the level of DNA end resection, the initial steps of the homologous recombination repair pathway. On the other hand, most cellular and organismal activities follow a 24 h oscillation known as the circadian cycle. Such repetitive changes are controlled by an intrinsic, molecular clock built-in at the cellular level which core components are the heterodimers BMAL1-CLOCK and CRY-PER. These inherent rhythms control many different aspects of the cellular metabolism, including the fate of many different DNA transactions. Here we have explored the regulation of the choice between different DNA double strand break repair pathways along the circadian cycle. We observed that DNA end resection shows a circadian oscillation, with a peak at dawn followed by a progressive reduction until dusk. Such regulations depend on the cellular levels of the circadian clock core component CRY1. Consequently, repair by homologous recombination mirrors CRY1 expression levels. Such modulation is controlled through the circadian regulation of the anti-resection activity, but not the protein levels, of CCAR2, that limits CtIP-mediated resection preferentially at nightfall. Additionally, such regulation requires a crosstalk between the DNA damage-dependent phosphorylation of CRY1 by the kinase DNA-PK. Finally, such regulation has an impact in cancer progression and response to radiation therapy of specific tumors. One sentence summary CCAR2-dependent inhibition of DNA end resection and homologous recombination is controlled by the intrinsic cellular circadian clock
Open AccessCircadian regulation of Homologous Recombination by Cryptochrome1-mediated dampening of DNA end resection
The maintenance of genomic stability is essential for cellular and organismal survival and fitness. Thus, when DNA gets damaged, is essential to repair it in the most accurate fashion. Among different DNA lesions, DNA double strand breaks are specially challenging. An exquisite regulatory network reacts to local and global cues to control the choice between different DNA double strand break repair mechanisms to maximize genomic integrity. Such regulation relies mostly at the level of DNA end resection, the initial steps of the homologous recombination repair pathway. On the other hand, most cellular and organismal activities follow a 24 h oscillation known as the circadian cycle. Such repetitive changes are controlled by an intrinsic, molecular clock built-in at the cellular level which core components are the heterodimers BMAL1-CLOCK and CRY-PER. These inherent rhythms control many different aspects of the cellular metabolism, including the fate of many different DNA transactions. Here we have explored the regulation of the choice between different DNA double strand break repair pathways along the circadian cycle. We observed that DNA end resection shows a circadian oscillation, with a peak at dawn followed by a progressive reduction until dusk. Such regulations depend on the cellular levels of the circadian clock core component CRY1. Consequently, repair by homologous recombination mirrors CRY1 expression levels. Such modulation is controlled through the circadian regulation of the anti-resection activity, but not the protein levels, of CCAR2, that limits CtIP-mediated resection preferentially at nightfall. Additionally, such regulation requires a crosstalk between the DNA damage-dependent phosphorylation of CRY1 by the kinase DNA-PK. Finally, such regulation has an impact in cancer progression and response to radiation therapy of specific tumors. One sentence summary CCAR2-dependent inhibition of DNA end resection and homologous recombination is controlled by the intrinsic cellular circadian clock
- Open Access
- 21 May 2020
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 48 (9) , 4915-4927
PHF2 regulates homology-directed DNA repair by controlling the resection of DNA double strand breaks
Post-translational histone modifications and chromatin remodelling play a critical role controlling the integrity of the genome. Here, we identify histone lysine demethylase PHF2 as a novel regulator of the DNA damage response by regulating DNA damage-induced focus formation of 53BP1 and BRCA1, critical factors in the pathway choice for DNA double strand break repair. PHF2 knockdown leads to impaired BRCA1 focus formation and delays the resolution of 53BP1 foci. Moreover, irradiation-induced RPA phosphorylation and focus formation, as well as localization of CtIP, required for DNA end resection, to sites of DNA lesions are affected by depletion of PHF2. These results are indicative of a defective resection of double strand breaks and thereby an impaired homologous recombination upon PHF2 depletion. In accordance with these data, Rad51 focus formation and homology-directed double strand break repair is inhibited in cells depleted for PHF2. Importantly, we demonstrate that PHF2 knockdown decreases CtIP and BRCA1 protein and mRNA levels, an effect that is dependent on the demethylase activity of PHF2. Furthermore, PHF2-depleted cells display genome instability and are mildly sensitive to the inhibition of PARP. Together these results demonstrate that PHF2 promotes DNA repair by homologous recombination by controlling CtIP-dependent resection of double strand breaks.
- 21 May 2020
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 48 (9) , 4915-4927
Open AccessPHF2 regulates homology-directed DNA repair by controlling the resection of DNA double strand breaks
Post-translational histone modifications and chromatin remodelling play a critical role controlling the integrity of the genome. Here, we identify histone lysine demethylase PHF2 as a novel regulator of the DNA damage response by regulating DNA damage-induced focus formation of 53BP1 and BRCA1, critical factors in the pathway choice for DNA double strand break repair. PHF2 knockdown leads to impaired BRCA1 focus formation and delays the resolution of 53BP1 foci. Moreover, irradiation-induced RPA phosphorylation and focus formation, as well as localization of CtIP, required for DNA end resection, to sites of DNA lesions are affected by depletion of PHF2. These results are indicative of a defective resection of double strand breaks and thereby an impaired homologous recombination upon PHF2 depletion. In accordance with these data, Rad51 focus formation and homology-directed double strand break repair is inhibited in cells depleted for PHF2. Importantly, we demonstrate that PHF2 knockdown decreases CtIP and BRCA1 protein and mRNA levels, an effect that is dependent on the demethylase activity of PHF2. Furthermore, PHF2-depleted cells display genome instability and are mildly sensitive to the inhibition of PARP. Together these results demonstrate that PHF2 promotes DNA repair by homologous recombination by controlling CtIP-dependent resection of double strand breaks.
- 1 July 2018
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 521, 197-205
Importance of hydrophobic interactions in the single-chained cationic surfactant-DNA complexation
- 1 July 2018
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 521, 197-205
Importance of hydrophobic interactions in the single-chained cationic surfactant-DNA complexation
- Open Access
- 24 July 2017
- Published by Springer Nature in Nature Communications
- Vol. 8 (1) , 1-11
DNA end resection requires constitutive sumoylation of CtIP by CBX4
DNA breaks are complex DNA lesions that can be repaired by two alternative mechanisms: non-homologous end-joining and homologous recombination. The decision between them depends on the activation of the DNA resection machinery, which blocks non-homologous end-joining and stimulates recombination. On the other hand, post-translational modifications play a critical role in DNA repair. We have found that the SUMO E3 ligase CBX4 controls resection through the key factor CtIP. Indeed, CBX4 depletion impairs CtIP constitutive sumoylation and DNA end processing. Importantly, mutating lysine 896 in CtIP recapitulates the CBX4-depletion phenotype, blocks homologous recombination and increases genomic instability. Artificial fusion of CtIP and SUMO suppresses the effects of both the non-sumoylatable CtIP mutant and CBX4 depletion. Mechanistically, CtIP sumoylation is essential for its recruitment to damaged DNA. In summary, sumoylation of CtIP at lysine 896 defines a subpopulation of the protein that is involved in DNA resection and recombination.
- 24 July 2017
- Published by Springer Nature in Nature Communications
- Vol. 8 (1) , 1-11
Open AccessDNA end resection requires constitutive sumoylation of CtIP by CBX4
DNA breaks are complex DNA lesions that can be repaired by two alternative mechanisms: non-homologous end-joining and homologous recombination. The decision between them depends on the activation of the DNA resection machinery, which blocks non-homologous end-joining and stimulates recombination. On the other hand, post-translational modifications play a critical role in DNA repair. We have found that the SUMO E3 ligase CBX4 controls resection through the key factor CtIP. Indeed, CBX4 depletion impairs CtIP constitutive sumoylation and DNA end processing. Importantly, mutating lysine 896 in CtIP recapitulates the CBX4-depletion phenotype, blocks homologous recombination and increases genomic instability. Artificial fusion of CtIP and SUMO suppresses the effects of both the non-sumoylatable CtIP mutant and CBX4 depletion. Mechanistically, CtIP sumoylation is essential for its recruitment to damaged DNA. In summary, sumoylation of CtIP at lysine 896 defines a subpopulation of the protein that is involved in DNA resection and recombination.
- Open Access
- 10 March 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (16) , 27380-27392
Targeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancer
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Noa Rabinowicz1, 2, Lingegowda S. Mangala3, 4, Kevin R. Brown5, Cintia Checa-Rodriguez6, Asher Castiel1, 2, Oren Moskovich1, 2, Giulia Zarfati1, Luba Trakhtenbrot1, Adva Levy-Barda1, Dahai Jiang3, 4, Cristian Rodriguez-Aguayo4, 7, Sunila Pradeep3, Yael van Praag1, Gabriel Lopez-Berestein4, 7, Ahuvit David1, 2, Ilya Novikov9, Pablo Huertas6, Robert Rottapel10, Anil K. Sood3, 4, 8, Shai Izraeli1, 2, 11 1Cancer Research Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel 2Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel 3Department of Gynecologic Oncology, MD Anderson Cancer Center, Houston, Texas, USA 4Center for RNA Interference and Non-Coding RNA, MD Anderson Cancer Center, Houston, Texas, USA 5Donnelly Centre and the Banting and Best Department of Medical Research, University of Toronto, Toronto, ON, Canada 6Department of Genetics, University of Sevilla and Centro Andaluz de Biología Molecular y Medicina Regenerativa (CABIMER), Sevilla, Spain 7Department of Experimental Therapeutics, MD Anderson Cancer Center, Houston, Texas, USA 8Department of Cancer Biology, MD Anderson Cancer Center, Houston, Texas, USA 9Biostatistical Unit, Gertner Institute for Epidemiology and Health Policy Research, Israel 10Princess Margaret Cancer Center, University Health Network, Toronto, ON, Canada 11The Gene Development and Environment Pediatric Research Institute, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Tel Hashomer, Israel Correspondence to: Shai Izraeli, email: sizraeli@sheba.health.gov.il Keywords: STIL, centrosomes, ovarian cancer, DNA damage, genomic instability Received: August 11, 2016 Accepted: February 20, 2017 Published: March 10, 2017
- 10 March 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (16) , 27380-27392
Open AccessTargeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancer
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Noa Rabinowicz1, 2, Lingegowda S. Mangala3, 4, Kevin R. Brown5, Cintia Checa-Rodriguez6, Asher Castiel1, 2, Oren Moskovich1, 2, Giulia Zarfati1, Luba Trakhtenbrot1, Adva Levy-Barda1, Dahai Jiang3, 4, Cristian Rodriguez-Aguayo4, 7, Sunila Pradeep3, Yael van Praag1, Gabriel Lopez-Berestein4, 7, Ahuvit David1, 2, Ilya Novikov9, Pablo Huertas6, Robert Rottapel10, Anil K. Sood3, 4, 8, Shai Izraeli1, 2, 11 1Cancer Research Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel 2Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel 3Department of Gynecologic Oncology, MD Anderson Cancer Center, Houston, Texas, USA 4Center for RNA Interference and Non-Coding RNA, MD Anderson Cancer Center, Houston, Texas, USA 5Donnelly Centre and the Banting and Best Department of Medical Research, University of Toronto, Toronto, ON, Canada 6Department of Genetics, University of Sevilla and Centro Andaluz de Biología Molecular y Medicina Regenerativa (CABIMER), Sevilla, Spain 7Department of Experimental Therapeutics, MD Anderson Cancer Center, Houston, Texas, USA 8Department of Cancer Biology, MD Anderson Cancer Center, Houston, Texas, USA 9Biostatistical Unit, Gertner Institute for Epidemiology and Health Policy Research, Israel 10Princess Margaret Cancer Center, University Health Network, Toronto, ON, Canada 11The Gene Development and Environment Pediatric Research Institute, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Tel Hashomer, Israel Correspondence to: Shai Izraeli, email: sizraeli@sheba.health.gov.il Keywords: STIL, centrosomes, ovarian cancer, DNA damage, genomic instability Received: August 11, 2016 Accepted: February 20, 2017 Published: March 10, 2017
- Open Access
- 1 February 2017
- Published by Elsevier in Stem Cell Reports
- Vol. 8 (2) , 432-445
CtIP-Specific Roles during Cell Reprogramming Have Long-Term Consequences in the Survival and Fitness of Induced Pluripotent Stem Cells
- 1 February 2017
- Published by Elsevier in Stem Cell Reports
- Vol. 8 (2) , 432-445
Open AccessCtIP-Specific Roles during Cell Reprogramming Have Long-Term Consequences in the Survival and Fitness of Induced Pluripotent Stem Cells